Abstract
Bacterial DNA is immunostimulatory due to the presence of specific unmethylated CpG-containing sequences (1). The activity of bacterial DNA can be mimicked by oligonucletides (ODN) (2), and this has been critical in establishing the sequence requirements for activation. Both native phosphodiester oligonucleotides and phosphorothioate-modified oligonucleotides (PO-ODN and PS-ODN) of various sequences can activate macrophages, dendritic cells, and B lymphocytes. Although PO-ODN are the most relevant to the role of bacterial or viral DNA in the host response to infection, stabilized synthetic oligonucleotides have great potential in immunotherapy. Normal phosphodiester oligonucleotides are short-lived in vivo (3) and incapable of giving effective therapeutic immunostimulation. The most frequent means of stabilizing oligonucleotides is by phosphorothioate modification of the backbone, whereby one of the nonbridging oxygens of the phosphate group is converted to sulfur. Phosphorothioates are poor substrates for most cellular nucleases. CpG PS-ODN display many of the activities of bacterial DNA, but owing to evidence of phosphorothioate-specific activity, caution has been urged in their use as a model of bacterial DNA in infection (4,5). Although PS-ODN are now widely used in studies on the immunostimulatory effects of CpG-containing DNA, it is appropriate to ask whether they mimic all the actions of native phosphodiester DNA.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Krieg, A. M., Yi, A.-K., Matson, S., et al. (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546–549.
Yamamoto, S., Yamamoto, T., Kataoka, T., Kuramoto, E., Yano, O., and Tokunaga, T. (1992) Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity. J. Immunol. 148, 4072–4076.
Agrawal, S., Temsamani, J., Galbraith, W., and Tang, J. (1995) Pharmacokinetics of antisense oligonucleotides. Clin. Pharmacokinet. 28, 7–16.
Pisetsky, D. S. and Reich, C. F. (1999) Influence of backbone chemistry on immune activation by synthetic oligonucleotides. Biochem. Pharmacol. 58, 1981–1988.
Pisetsky, D. S. (1999) The influence of base sequence on the immunostimulatory properties of DNA. Immunol. Res. 19, 35–46.
Zhao, Q., Song, X., Waldschmidt, T., Fisher, E., and Krieg, A. M. (1996) Oligonucleotide uptake in human hematopoietic cells is increased in leukemia and is related to cellular activation. Blood 88, 1788–1795.
Branda, R. F., Moore, A. L., Mathews, L., McCormack, J. J. and Zon, G. (1993) Immune stimulation by an antisense oligomer complementary to the rev gene of HIV-1. Biochem. Pharmacol. 45, 2037–2043.
Krieg, A. M., Matson, S., and Fisher, E. (1996) Oligodeoxynucleotide modifications determine the magnitude of B cell stimulation by CpG motifs. Antisense Nucleic Acid Drug Dey. 6, 133–139.
Monteith, D. K., Henry, S. P., Howard, R. B., et al. (1997) Immune stimulation- a class effect of phosphorothioate oligodeoxynucleotides in rodents. Anticancer Drug Res. 12, 421–432.
Liang, H., Nishioka, Y., Reich, C. F., Pisetsky, D. S., and Lipsky, P. E. (1996) Activation of human B cells by phosphorothioate oligodeoxynucleotides. J. Clin. Invest. 98, 1119–1129.
Krieg, A. M., Hartmann, G., and Yi, A.-K. (2000) Mechanism of action of CpG DNA. Curr. Top. Microbiol. Immunol. 247, 1–21.
Boggs, R. T., McGraw, K., Condon, T., Condon, S. F., Villiet, P., Bennett, F. and Monia, B. P. (1997) Characterization and modulation of immune stimulation by modified oligonucleotides. Antisense Nucl. Acid Drug Dey. 7, 461–471.
Yi, A.-K., Chace, J. H., Cowdery, J. S., and Krieg, A. M. (1996) IFN-γ promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides. J. Immunol. 156, 558–564.
Hartmann, G., Weiner, G. J. and Krieg, A. M. (1999) CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc. Natl. Acad. Sci. USA 96, 9305–9310.
Jakob, T., Walker, P. S., Krieg, A. M., Udey, M. C., and Vogel, J. C. (1998) Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Thl responses by immunostimulatory DNA. J. Immunol. 161, 3042–3049.
Kadowaki, N., Antonenko, S., and Liu, Y. J. (2001) Distinct CpG DNA and polyinosinic-polycytidylic acid double-stranded rna, respectively, stimulate CD 11 c(-) type 2 dendritic cell precursors and CD11 c(+) dendritic cells to produce type I IFN. J. Immunol. 166, 2291–2295.
Lapatschek, M. S., Gilbert, R. L., Wagner, H., and Miethke, T. (1998) Activation of macrophages and B lymphocytes by an oligodeoxynucleotide derived from an acutely pathogenic simian immunodeficiency virus. Antisense Nucleic Acid Drug Dev. 8, 357–370.
Hartmann, G. and Krieg, A. M. (2000) Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J. Immunol. 164, 944–953.
Mannon, R. B., Nataraj, C. and Pisetsky, D. S. (2000) Stimulation of thymocyte proliferation by phosphorothioate DNA oligonucleotides. Cell. Immunol. 201, 14–21.
Ballas, Z. K., Rasmussen, W. L. and Krieg, A. M. (1996) Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol. 157, 1840–1845.
Lee, S. W., Song, M. K., Baek, K. H., et al. (2000) Effects of a hexameric deoxyriboguanosine run conjugation into CpG oligodeoxynucleotides on their immunostimulatory potentials. J. Immunol. 165, 3631–3639.
Verthelyi, D., Ishii, K., Gursel, M., Takeshita, F., and Klinman, D. (2001) Human peripheral blood cells differentially recognize and respond to two distinct CpG motifs. J. Immunol. 166, 2372–2377.
Pisetsky, D. S. and Reich, C. F. (2000) Inhibition of murine macrophage IL-12 production by natural and synthetic DNA. Clin. Immunol. 96, 198–204.
Lang, R., Hultner, L., Lipford, G. B., Wagner, H., and Heeg, K. (1999) Guanosine-rich oligodeoxynucleotides induce proliferation of macrophage progenitors in cultures of murine bone marrow cells. Eur. J. Immunol. 29, 3496–3506.
Stacey, K. J., Sweet, M., and Hume, D. A. (1996) Macrophages ingest and are activated by bacterial DNA. J. Immunol. 157, 2116–2122.
Sweet, M. J., Stacey, K. J., Kakuda, D. K., Markovich, D. and Hume, D. A. (1998) IFN-γ primes macrophage responses to bacterial DNA. J. Interferon Cytokine Res. 18, 263–271.
Sester, D. P., Naik, S., Beasley, S. J., Hume, D. A., and Stacey, K. J. (2000) Phosphorothioate backbone modification modulates macrophage activation by CpG DNA. J. Immunol. 165, 4165–4173.
Schindler, U. and Baichwal, V. R. (1994) Three NF-kB binding sites in the human E-selectin gene required for maximal tumor necrosis factor a-induced expression. Mol. Cell Biol. 14, 5820–5831.
Sester, D. P., Beasley, S. J., Sweet, M. J., et al. (1999) Bacterial/CpG DNA Down-Modulates Colony Stimulating Factor-1 Receptor Surface Expression on Murine Bone Marrow-Derived Macrophages with Concomitant Growth Arrest and Factor-Independent Survival. J. Immunol. 163, 6541–6550.
Häcker, H., Mischak, H., Hacker, G., et al. (1999) Cell type-specific activation of mitogen-activated protein kinases by CpG-DNA controls interleukin-12 release from antigen-presenting cells. EMBO J. 18, 6973–6982.
Yi, A. K. and Krieg, A. M. (1998) Cutting edge: Rapid induction of mitogenactivated protein kinases by immune stimulatory CpG DNA. J. Immunol. 161, 4493–4497.
Takeshita, F., Ishii, K. J., Ueda, A., Ishigatsubo, Y., and Klinman, D. M. (2000) Positive and negative regulatory elements contribute to CpG oligonucleotide-mediated regulation of human IL-6 gene expression. Eur. J. Immunol. 30, 108–116.
Takeshita, F. and Klinman, D. M. (2000) CpG ODN-mediated regulation of IL-12 p40 transcription. Eur. J. Immunol. 30, 1967–1976.
Chu, W., Gong, X., Li, Z., et al. (2000) DNA-PKcs is required for activation of innate immunity by immunostimulatory DNA. Cell 103, 909–918.
Takakura, Y., Oka, Y., and Hashida, M. (1998) Cellular uptake properties of oligonucleotides in LLC-PK1 renal epithelial cells. Antisense Nucl. Acid Drug Dev. 8, 67–73.
Zhao, Q., Matson, S., Herrara, C. J., et al. (1993) Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides. Antisense Res. Dev. 3, 53–56.
Nakai, D., Seita, T., Terasaki, T., et al. (1996) Cellular uptake mechanism for oligonucleotides: Involvement of endocytosis in the uptake of phosphodiester oligonucleotides by a human colorectal adenocarcinoma cell line, HCT-15. J. Pharmacol. Exp. Ther. 278, 1362–1372.
Tonkinson, J. L. and Stein, C. A. (1994) Patterns of intracellular compartmentalization, trafficking and acidification of 5′-fluorescein labeled phosphodiester and phosphorothioate oligodeoxynucleotides in HL60 cells. Nucl. Acids Res. 22, 4268–4275.
Beltinger, C., Saragovi, H. U., Smith, R. M., et al. (1995) Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. J. Clin. Invest. 95, 1814–1823.
Bennett, R. M. (1993) As nature intended? The uptake of DNA and oligonucleotides by eukaryotic cells. Antisense Res. Dev. 3, 235–241.
Benimetskaya, L., Loike, J. D., Khaled, Z., et al. (1997) Mac-1 (CD 11 b/CD 18) is an oligodeoxynucleotide-binding protein. Nature Med. 3, 414–420.
Häcker, H., Mischak, H., Miethke, T., et al. (1998) CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by nonspecific endocytosis and endosomal maturation. EMBO J. 17, 6230–6240.
Hartmann, G., Krug, A., Waller-Fontaine, K., and Endres, S. (1996) Oligodeoxynucleotides enhance lipopolysaccharide-stimulated synthesis of tumor necrosis factor:dependence on phosphorothioate modification and reversal by heparin. Mol. Med. 2, 429–438.
Perez, J. R., Li, Y., Stein, C. A., Majumder, S., van Oorschot, A., and Narayanan, R. (1994) Sequence-independent induction of Sp 1 transcription factor activity by phosphorothioate oligodeoxynucleotides. Proc. Natl Acad. Sci. USA 91, 5957–5961.
Neckers, L. M. and Iyer, K. (1997) Non-antisense effects of antisense oligonucleotides, in Antisense oligodeoxynucleotides and antisense RNA (Weiss, B., ed.), CRC Press, Boca Raton, pp. 80–89.
Stein, C. A. (1996) Phosphorothioate antisense oligodeoxynucleotides: questions of specificity. Trends Biotechnol. 14, 147–149.
Eckstein, F. (2000) Phosphorothioate oligodeoxynucleotides: what is their origin and what is unique about them? Antisense Nucleic Acid Drug Dev. 10, 117–121.
Khaled, Z., Rideout, D., O’Driscoll, K. R., et al. (1995) Effects of suraminrelated and other clinically therapeutic polyanions on protein kinase C activity. Clin. Cancer Res. 1, 113–122.
Rockwell, P., O’Connor, W. J., King, K., Goldstein, N. I., Zhang, L. M., and Stein, C. A. (1997) Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides. Proc. Natl. Acad. Sci. USA 94, 6523–6528.
Underhill, D. M., Ozinsky, A., Hajjar, A. M., et al. (1999) The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401, 811–815.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Stacey, K.J., Sester, D.P., Naik, S., Roberts, T.L., Sweet, M.J., Hume, D.A. (2002). Phosphorothioate Backbone Modification Changes the Pattern of Responses to CpG. In: Raz, E. (eds) Microbial DNA and Host Immunity. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-305-7_6
Download citation
DOI: https://doi.org/10.1007/978-1-59259-305-7_6
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4684-9728-1
Online ISBN: 978-1-59259-305-7
eBook Packages: Springer Book Archive